The difference between a dose that is 10% too high and one that is 10% too low might come down to which syringe you selected
Expanding clinical evidence is likely to increase payer review of GLP-1 drugs across diabetes and weight management programs
PlexusDx positions precision assessmentincluding optional genetic testingas foundational to selecting a treatment protocol that aligns with your clinical profile and budget
Preclinical studies have explored BPC-157 in models of tendon and ligament injury, gut barrier dysfunction, gastric ulceration, bone fracture healing, peripheral nerve repair, and anti-inflammatory activity
PlexusDx compounded semaglutide injections activate the same GLP-1 receptors as brand-name options, starting at $189 per month
From a purely cosmetic endpoint, Melanotan II wins the head-to-head